2015
DOI: 10.5056/jnm15078
|View full text |Cite
|
Sign up to set email alerts
|

TRPC3: A New Target for Therapeutic Strategies in Chronic Pain−DAG-mediated Activation of Non-selective Cation Currents and Chronic Pain (Mol Pain 2014;10:43)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 10 publications
0
7
0
Order By: Relevance
“…We focused on the synaptogenesis pathway in particular, as it includes several genes present in overlapping canonical pathways, including changes in receptors involved in organization of excitatory signaling (Ephb) and synapses which may be involved in development of chronic pain (TrkB and BDNF). We validated receptors for significant genes in the synaptogenesis pathway, and genes considered possible contributors to pain that also showed significant differences between conditions Gabrg3, Il6st, Kcng3, Piezo2, Scn5a, Trpc3;Waxman et al, 1999;Wickenden, 2002;De Jongh et al, 2003;Devor, 2006;Eijkelkamp et al, 2013;Guptarak et al, 2013;Xia et al, 2015;Deng et al, 2018;Szczot et al, 2018). Additional targets were chosen in order to validate isolation of the correct cell population (Scn10a).…”
Section: Validation Of Rnaseq Data Using Qpcrmentioning
confidence: 99%
“…We focused on the synaptogenesis pathway in particular, as it includes several genes present in overlapping canonical pathways, including changes in receptors involved in organization of excitatory signaling (Ephb) and synapses which may be involved in development of chronic pain (TrkB and BDNF). We validated receptors for significant genes in the synaptogenesis pathway, and genes considered possible contributors to pain that also showed significant differences between conditions Gabrg3, Il6st, Kcng3, Piezo2, Scn5a, Trpc3;Waxman et al, 1999;Wickenden, 2002;De Jongh et al, 2003;Devor, 2006;Eijkelkamp et al, 2013;Guptarak et al, 2013;Xia et al, 2015;Deng et al, 2018;Szczot et al, 2018). Additional targets were chosen in order to validate isolation of the correct cell population (Scn10a).…”
Section: Validation Of Rnaseq Data Using Qpcrmentioning
confidence: 99%
“…Dysfunction of TRPC3 has been linked to neurodegenerative disease, cardiac hypertrophy, and ovarian adenocarcinoma ( Becker et al, 2011 ; Kitajima et al, 2016 ; Yang et al, 2009 ). Although TRPC3 has wide pharmaceutical applications in treatment of these diseases, drug development specifically targeting TRPC3 has been limited due to the lack of understanding of its molecular activation mechanisms ( Oda et al, 2017 ; Xia et al, 2015 ). Here, we report the structure of full-length human TRPC3 (hTRPC3) in a lipid-occupied, inactive state at an atomic resolution of 3.3 Å using single-particle cryo-electron microscopy (cryo-EM).…”
Section: Introductionmentioning
confidence: 99%
“…This suggests that the high TRPC3 expression in the peripheral nerves or an increase in the T allele number was associated with the higher risk of chronic pain in the present study. In the thoracolumbar DRGs in rats, the prolonged elevations of intracellular calcium can cause neuronal hyperexcitability and hypersensitivity, leading to nociception and chronic pain [ 26 ].…”
Section: Discussionmentioning
confidence: 99%
“…The TRPC3 channels, as well as other TRP channels (e.g., TRPV1, TRPV3, TRPV4, TRPA1, TRPM3, and TRPM8), possibly play an important role in nociception [ 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 26 ]. In humans, TRPC3 mRNA is highly expressed in the brain, including the cervical spinal cord and heart [ 32 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation